INTRODUCTION
Public health statistics over the past decade have shown an increase in the incidence of low birth weight (LBW) deliveries as well as a significantly higher rate of survival for infants with birth weights <750 g. [1] [2] [3] [4] Follow-up studies on children who weighed r1250 g at birth have reported multiple morbidities, functional impairments and severe retinopathy of prematurity (ROP). 5, 6 In addition, eyeglasses have been reported to be a compensatory aid that differentiates extreme low birth weight (ELBW) children from LBW children. 5, 7 A recently completed, multicenter longitudinal study followed 1063 children, whose birth weight was r1250 g, from birth to 5.5 years of age. 7 Threshold ROP had been diagnosed and treated, using peripheral ablation with cryotherapy, in 223 of these children. Severe disability, as defined by a WeeFIM 7 score of <77, was reported in 19.7% of children with threshold/treated ROP. The severity of neonatal ROP was reported to be a ''marker for functional disability at 5.5 years''. 7 Advances in neonatal care over the past decade have been studied in relation to the occurrence of ROP. Studies evaluating the occurrence and severity of ROP related to pre-and postsurfactant use in the Netherlands and Australia have shown conflicting results concerning the impact of this recent therapy. 8 In 1997, Kennedy et al. 9 noted that improved survival rates postsurfactant were associated with a greater number of children at risk for ROP. A study of 89 patients born in 1986 to 1987 and 92 patients born in 1995 to 1996 with birth weights <1251 g from the Vanderbilt Neonatal Intensive Care Unit found, however, a significantly decreased occurrence in ROP despite increased survival rates among these children. 10 The Vanderbilt group suggested that the decreased occurrence could be related to the increased use of surfactant and antenatal steroids, continuous pulse oximetry, and improved nutritional support. The use of continuous pulse oximetry to maintain a lower saturation of 70% to 90% for infants born at less than 28 weeks has been shown to lower the occurrence of threshold ROP. 11 Although advances in perinatal and neonatal technologies have resulted in decreased neonatal death rates, the rates of neurodevelopmental sequelae for ELBW infants have remained the same. 12 Since severe ROP may be a ''marker'' for other disabilities, awareness of regional trends in the occurrence and severity of ROP are needed to estimate the needs for follow-up services.
The purpose of this study was to evaluate the occurrence and severity of ROP from January 1, 1994 through December 31, 2000 among infants <1250 g birth weight treated in the Women & Infants' Special Care Nursery (SCN). It was hypothesized that the incidence of threshold ROP increased during the study period because of increasing survival of infants <1250 g birth weight.
SUBJECTS AND METHODS
This was a retrospective review of the ROP data collected on infants with birth weights <1250 g combined with the Neonatal Follow-up Clinic database. Of 1002 infants born with birth weights <1250 g, 162 (16%) expired and 100 (10%) were transferred out to level II community facilities or discharged home prior to an initial 4-to 6-week eye exam. One patient had incomplete exam results. The subjects of this report included 739 infants who had ophthalmologic data. All infants who were discharged home or transferred early to a level II facility and who met the criteria for eye exams were scheduled for appropriate ophthalmologic exams either as outpatients or at the level II facility. Ophthalmologic data, however, were not available on the 100 infants transferred to other facilities. A comparison between the study subjects and the 100 infants transferred out prior to having eye exams revealed that those infants without eye exams had a higher birth weight (1097±133 vs 906±203 g, p<0.0001), higher gestational age (30±2 vs 27±2.3 weeks, p<0001), fewer days on oxygen (6±10 vs 40±33 days, p<0.0001) and fewer days on ventilation (2±2 and 13±14 days, p<0.0001, respectively). For patients without and with ophthalmologic data, medians and ranges for days on oxygen were 2(0 to 60) and 35(0 to 181), respectively. The median and ranges for days on ventilation for those without and with ophthalmologic data were 1(0 to 12) and 6(0 to 83), respectively.
Neonatal characteristics analyzed include the following: oxygen treatment at 36 weeks postmenstrual age (PMA), days on oxygen, days on ventilation, antenatal and postnatal steroid use, sepsis, necrotizing enterocolitis (NEC), 13 any intraventricular hemorrhage (IVH), IVH grade 3 to 4, patent ductus arteriosus (PDA), gestational age and gender.
Data on ROP were obtained from ophthalmologic examinations reported by the ophthalmologist assigned to the SCN. The International Classification for ROP was used. These exams were initiated at 4 to 6 weeks of age and repeated every 1 to 2 weeks, as recommended by the ophthalmologist. When retinal vascularization had progressed to Zone III, infants' eye exams were followed up every 4 weeks until the retina was fully vascularized, then at 6 months of age based on the ophthalmologist's recommendations. ROP data were entered into the database by one of the investigators (M. O'C.) and were classified as no ROP, less than prethreshold ROP, prethreshold ROP and threshold ROP (Table 1). 14,15
STATISTICAL ANALYSIS
Analysis of variance was used for continuous variables and w 2 for categorical measures. Linear trend analysis was used to evaluate the number of cases of ROP over time and the frequency of threshold ROP over 7 years. Logistic regression models were used to analyze the outcomes of dependent variables: prethreshold and threshold ROP or any ROP. The predictors analyzed included gestational age, birth weight categories (<750, 750 to 999, 1000 to 1250 g), and year of birth. The risk factors analyzed included number of days on oxygen, oxygen at 36 weeks postmenstrual age (PMA), number of days on ventilation, antenatal steroids, postnatal steroids, sepsis, necrotizing enterocolitis (NEC) (proven), any IVH and IVH grade 3 to 4. Table 2 shows the characteristics of the subjects by year of birth. There were no significant increases by year in the number of births or survivors. The mean birth weight and gestational age remained stable over the 7 years. The percent of infants who developed any ROP increased from 40% in 1994 to 54% in 2000 (w 2 for linear trend, p ¼ 0.007). The occurrence of threshold ROP was low and ranged from 2% to 5% (Pearson w 2 NS). The clinical characteristics and morbidities of the subjects in the four study groups are shown in Table 3 . The percent of infants with threshold ROP was inversely related to birth weight (p<0.001). There were no gender differences. Infants with threshold ROP had higher rates of days on oxygen, days on ventilation, postnatal steroids, sepsis NEC and IVH. The incidence of PDA and the race distribution of the study population, 17% black and 83% non-black infants, did not vary among groups and is not shown. Logistic regression models were performed to predict (1) the presence of any ROP and (2) the presence of prethreshold or threshold ROP. In the first regression, birth weight <750 g, lower gestation and postnatal steroids were all significantly associated with any ROP (Table 4 ). In the regression to predict prethreshold and threshold ROP (Table 5) , birth weight <750 g and oxygen at 36 weeks were significant.
RESULTS
Of the 29 infants who developed threshold ROP requiring laser treatment, two expired. Of the 27 remaining, 26 had follow-up clinic data available for 3, 7 and/or 18 months of age. Nine infants (34.6%) had complications of severe ROP including strabismus, nystagmus, myopia and late retinal detachment. Four of the nine infants (15.4%) were legally blind.
DISCUSSION
This study revealed an increase in the proportion of infants identified with ROP over 7 years at Women and Infants SCN. During the study period, gestational age and birth weight remained relatively stable for infants <1250 g. The proportion of infants with threshold ROP remained low at 2% to 5% (NS). The total number of infants with threshold ROP was small (n ¼ 29) and therefore we cannot rule out a type II error. Weight <750 g and low gestational age (Table 4) were associated with the presence of any ROP, as has been noted in previous studies. 16, 17 In our study population, 20 (69%) of the 29 infants with threshold ROP had a birth weight of <750 g and 21 (62%) of the 34 infants with prethreshold ROP had birth weights <750 g. Birth weight <750 g predicted prethreshold and threshold ROP in our multivariate models. The recently completed prospective EPICure study evaluated outcomes for 843 infants born at less than 26 weeks gestation in England and Ireland, and found that immaturity (as defined by low gestational age and birth weight) was related to severe ROP. 18 Both this study and our own suggest that severe ROP is related to immaturity.
On multivariate analysis, the duration of oxygen therapy was found to be significantly associated with severe ROP. Historically, the occurrence and severity of ROP has been repeatedly linked with oxygen therapy. [19] [20] [21] Some investigators have proposed that postnatal supplemental oxygen therapy may decrease ROP progression, 22 and a recent randomized control trial of supplemental therapeutic oxygen for infants with prethreshold ROP showed a 28% reduction in the progression of prethreshold to threshold ROP; however, the results were only borderline statistically significant. 23 A study by Tin et al. 11 found that nurseries with policies that maintained higher oxygen saturation levels (88% to 98%) in premature infants for the first few weeks of life had a fourfold increase in the rate of threshold ROP. Citing the link between sensitivity to oxygen toxicity and prematurity, Edmond et al. 24 analyzed cord blood and demonstrated a ''fetal'' disassociation curve in which a PaO 2 of 41 correlated to a hemoglobin saturation of 90%. Various authors are reconsidering the toxic risks of oxygen and attempting to redefine ''appropriate'' levels for preterm infants. 11, [25] [26] [27] In a recent observational cohort study, researchers at the UCLA evaluated the number of infants who developed ROP stage 3 to 4 after a new oxygen administration policy was adopted, and compared the number to historic controls. The policy set strict pulse oximetry parameters at 83% to 93% for infants r32 weeks gestation and limited adjustments in the fraction of inspired oxygen (FiO 2 ) to 2% to 5% as needed to wean oxygen or in response to hypoxia. 28 A decrease of stage 3 to 4 ROP from 38% to 10% to 12% was reported for infants with birth weights of 750 to 999 g. The pulse oximetry parameters at Women and Infants' Hospital, SCN, are set at 82% to 92% for infants r32 weeks gestation and the rates of prethreshold and threshold ROP are similar to those at UCLA.
The relationship between antenatal steroids and ROP has been controversial. A 1998 observational cohort study of 63 very LBW infants controlled for severity of illness (RDS, BPD, PDA) and baseline characteristics (GA and BW) using multiple regression analysis reported that administration of antenatal steroids was associated with a significant decrease in the severity of ROP. 29 Currently, the majority of very LBW infants (77% of our study population) are exposed to antenatal steroids, thereby impeding the ability to evaluate in multivariate analysis.
Infants who receive postnatal steroid treatment are presumably those with severe RDS, who have greater needs for assisted ventilation and oxygen therapy, thereby placing them at a higher risk for ROP. The 2002 AAP Consensus Statement on postnatal corticosteroid therapy reported no differences in the incidence of severe retinopathy of prematurity for infants treated with postnatal steroids for chronic lung disease compared to infants not treated. 30 Our study, however, found a significant association between postnatal steroid use and the development of any ROP and a borderline association with severe ROP. Among the infants with threshold ROP, 23 of 29 (79%) received postnatal steroids. A study 31 Other studies have refuted this association and found that the duration of oxygen therapy, birth weight and severity of pulmonary disease were the important predictors for severe ROP. [32] [33] [34] [35] The mechanisms for the development of IVH, a common serious neurologic complication for infants, have been related to the mechanism for the development of ROP. 36, 37 IVH grade 3 to 4 was observed in only 47 of the 739 infants in our study, and, although bivariate analysis showed an association between IVH grade 3 to 4 and ROP, the small number of cases may have limited our ability to identify an association with multiple regression analysis.
Retinal pigmentation with large amounts of melanin has been reported to be a ''protective'' factor inhibiting the development of ROP. 14, 20 Two authors listed ''nonblack'' infants as being at higher risk for ROP. 14, 39 In the current study, there were no significant differences found in ROP rates when comparing individual races and ROP or comparing black and non-black race.
In summary, we identified an increase in the occurrence of ROP during the 7-year study period, 1994 to 2000. Extreme LBW (<750 g), low gestational age and need for oxygen therapy at 36 weeks PMA were found to be independent predictors for severe prethreshold or threshold ROP. It is reassuring that, although the overall rate of ROP is increasing, the rate of threshold ROP as a major morbidity remains low. Infants at greatest risk remain those micropremies with birth weights <750 g.
